TMO
Thermo Fisher Scientific Inc.
- Depreciation and amortization, 2025
- $2.8B
- YoY, 2025
- −10.6%
- 5-year CAGR
- +3.6%
- 10-year CAGR
- +5.1%
Depreciation and amortization
Depreciation and amortization by fiscal year
| Period | D&A | YoY |
|---|---|---|
| 2025 | $2.8B | −10.6% |
| 2024 | $3.1B | −8.7% |
| 2023 | $3.4B | +0.7% |
| 2022 | $3.4B | +30.4% |
| 2021 | $2.6B | +11.5% |
| 2020 | $2.3B | +2.1% |
| 2019 | $2.3B | +0.4% |
| 2018 | $2.3B | +11.5% |
| 2017 | $2.0B | +15.6% |
| 2016 | $1.8B | +4.1% |
| 2015 | $1.7B | +0.2% |
| 2014 | $1.7B | +68.5% |
| 2013 | $1,000M | +1.6% |
| 2012 | $984M | +14.4% |
| 2011 | $860M | +16.2% |
| 2010 | $740M | −3.0% |
| 2009 | $763M | −3.8% |
| 2008 | $793M | +4.7% |
| 2007 | $757M | — |